{{Rsnum
|rsid=75076352
|Chromosome=10
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=RET
|position=43114500
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=RET
}}{{omim
|id=164761
|rsnum=75076352
|variant=0011
}}{{ClinVar
|rsid=75076352
|Reversed=0
|FwdREF=T
|FwdALT=A,C,G
|REF=T
|ALT=A,C,G
|RSPOS=43609948
|CHROM=10
|dbSNPBuildID=131
|SSR=0
|SAO=3
|VP=0x050068000000000002110124
|GENEINFO=RET:5979
|GENE_NAME=RET
|GENE_ID=5979
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000010.10:g.43609948T>A; NC_000010.10:g.43609948T>C; NC_000010.10:g.43609948T>G
|CLNSRC=Emory University; OMIM Allelic Variant
|CLNORIGIN=0
|CLNSRCID=3095; 164761.0002; 164761.0011; 164761.0003
|CLNSIG=5
|CLNCUI=C0025268; C0031511,C0025268; C0031511
|CLNDBN=MEN2A and Unclassified; Multiple endocrine neoplasia, type 2a; Pheochromocytoma; MEN2A and FMTC; not provided
|Disease=MEN2A and Unclassified; Multiple endocrine neoplasia; Pheochromocytoma; MEN2A and FMTC; not provided
|CLNACC=RCV000021820.1; RCV000014920.24; RCV000014937.24; RCV000014938.24; RCV000021821.1; RCV000082051.1; RCV000014922.24; RCV000014923.24; RCV000021822.1
|Tags=PM;PMC;OTHERKG;LSD;OM;NOV
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:Orphanet:SNOMED_CT; GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1257:C0025268:171400:247698:653:61808009; NBK1548:C0031511:171300:29072
}}{{PMID|3078962}} Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

{{PMID|7907913}} Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

{{PMID|8825918|OA=1
}} Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

{{PMID|9111993}} A Cys634Gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis.

{{PMID|12000816}} Germ-line mutations in nonsyndromic pheochromocytoma.

{{PMID|2904651}} Cushing's syndrome due to ectopic ACTH secretion by bilateral pheochromocytomas in multiple endocrine neoplasia type 2A.

{{PMID|3078962}} Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.

{{PMID|7849700}} Haplotype analysis of MEN 2 mutations.

{{PMID|7907913}} Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

{{PMID|10522989}} A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.